← Back to headlines
Citi Raises Gilead Price Target
Citi has increased its price target for Gilead Sciences (GILD) in anticipation of the company's upcoming Q1 Biopharma preview.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
